Phreesia, Inc. (PHR)

NYSE • Healthcare

$12.7

-$0.02 (-0.2%)

Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$12.55

Day Range$12.35 - $12.7

Avg. Volume (3M)662.2K

Market Cap$788.3M

P/E Ratio74.7

52 Week Range

$7.77$23.87

Next EarningsIn 50 daysDec 14, 2026

Metrics Over Time

Where the Money Goes

Q3 2026

Revenueeverything earned$129.4M100%

Gross Profitminus cost of goods$76.1M59%

Operating Incomeminus R&D and overhead$11M9%

Net Incomeminus taxes and the rest$1.9M1%

In plain terms: out of every $100 in revenue, Phreesia, Inc. keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)

$507.7M

Net Income (TTM)

$10.4M

EPS (TTM)

$0.17

ROA (TTM)

1.61%

Current Ratio

1.76

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+114.3%Q3 2025$0.01

+27877.8%Q4 2025$0.1

-67.4%Q1 2026$0.02

+150.0%Q2 2026$0.05

-64.7%Q3 2026$0.03

Dec 14

in 50 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -64.7%

Phreesia’s revenue rose 10.4% to about $129.5 million, while EPS of $0.03 trailed the $0.09 estimate (-65%) even as revenue of $129.5 million came in line with the $129.1 million consensus (+0.3%) for the second fiscal quarter of 2027 (period ended July 31, 2026) reported September 2, 2026, based on preliminary results. The top line was up from roughly $117.3 million a year ago, and GAAP net income increased 597.2% year over year to about $4.6 million (from roughly $0.7 million a year ago), alongside EPS up from $0.01 in the prior-year period. Cash generation was reflected in operating cash flow of about $18.3 million. For the next period, consensus calls for EPS of $0.12 on revenue of $128.1 million.

View full earnings history

About Phreesia, Inc.

Phreesia, Inc. (NYSE: PHR) provides healthcare software and payment tools for medical practices and health systems in the United States and Canada. Operating in healthcare information services, it generates $480.6 million of revenue in FY2026 through a cloud-based platform that handles patient intake, registration, and related administrative workflows.

Name

Phreesia, Inc.

CEO

Chaim Indig

Website

www.phreesia.com

Industry

Healthcare

Year Founded

2005

Employees

1,789

Today's Snapshot

AI-generated

PHR closed slightly lower at 12.70, while its sector was weaker.

Trading Volume

Below 10d avg (733.8K)

696.5K

vs S&P 500 Today

Moderate Outperformance

+0.36%

Updated: October 23, 2026 at 20:22 UTC

Technical Indicators

6 Buy0 Neutral2 Sell

PHR carries a Strong Buy profile with the stock trading around 12.70 and a clear alignment of short- and medium-term moving averages beneath the market that reflects broad bullish participation. Momentum readings are mixed: MACD and CCI point to strength while RSI and money flow are overbought, indicating short-term exhaustion. Trend power is solid with ADX near the mid-20s, and volume-based OBV confirms buying interest; volatility is moderate. The classic pivot sits just below the price, offering near-term support. Technical takeaway: bullish structural setup reinforced by volume, despite near-term overbought signals.

All signals